Fragmin 2500IU Injection contains an active component as dalteparin. It is a medication used to prevent and treat blood clots. It is a type of anticoagulant, specifically a low molecular weight heparin (LMWH). This medication works by inhibiting the formation of blood clots, which can help reduce the risk of conditions like deep vein thrombosis (DVT) and pulmonary embolism. Deep vein thrombosis (DVT) is a blood clot that forms in a deep vein, usually in the legs. At the same time, pulmonary embolism is a serious condition that occurs when a clot travels to the lungs, potentially causing life-threatening complications.

Fragmin 2500IU Injection has a more predictable anticoagulant response than unfractionated heparin, allowing for easier dosing and monitoring. It has a longer half-life, which means less frequent dosing is required compared to other anticoagulants, leading to better patient compliance. Unlike warfarin, which requires frequent international normalized ratio (INR) level monitoring, this medication typically does not need such monitoring. This medication has a lower bleeding risk than other anticoagulants, making them safer for certain patient populations. 

Individuals with a history of hypersensitivity or allergic reactions to Fragmin 2500IU Injection or other heparins should not use this medication. It is an anticoagulant that can increase the risk of bleeding. It should be used cautiously in patients with a history of bleeding disorders or active bleeding. Patients with severe kidney impairment may require dosage adjustments or alternative treatments, as this medication is primarily eliminated through the kidneys. It should be used cautiously in patients undergoing spinal or epidural anesthesia or lumbar puncture, as it may increase the risk of epidural or spinal hematomas, leading to paralysis.

Deep vein thrombosis (DVT).

Pulmonary embolism (PE).

Prevention of blood clots in medical setting.

The mechanism of action of Fragmin 2500IU Injection involves its ability to bind to antithrombin III, a natural anticoagulant in the body. This binding enhances antithrombin III's ability to inactivate clotting factors, particularly factor XA and, to a lesser extent, thrombin. By inhibiting these key clotting factors, this medication effectively prevents the formation of blood clots. It reduces the risk of thromboembolic events, such as deep vein thrombosis (DVT) and pulmonary embolism (PE).

Fragmin 2500IU Injection is typically administered as a subcutaneous injection (under the skin). The exact dosing and administration schedule will depend on the medical condition being treated, the patient's weight, and other individual factors. It is essential to follow the instructions provided by your healthcare professional or pharmacist carefully.

Signs of bleeding

Black or bloody stools

Coughing up blood or blood clots

Severe headache or weakness, especially on one side of the body

Sudden vision changes

Severe abdominal or back pain

Severe or persistent dizziness or fainting

Signs of an allergic reaction, including rash, itching, swelling

Bruising at the injection site

Mild pain or redness at the injection site

Bleeding from the gums or nose

Mild stomach upset or nausea

Mild headache

Itching or skin rash

Inform the doctor about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Fragmin 2500IU Injection, reducing effectiveness by causing undesirable side effects.

Store at room temperature, between 20°C to 25°C (68°F to 77°F).

Keep away from moisture, heat, and light.

It should not be frozen.

Keep away from children and pets.

Before using Fragmin 2500IU Injection, inform your healthcare provider about any bleeding disorders, history of heparin-induced thrombocytopenia, kidney or liver impairment, and any ongoing medications or medical conditions. Be vigilant for signs of bleeding, such as easy bruising or prolonged bleeding from cuts, and report any severe or persistent side effects promptly. Caution is advised when undergoing spinal or epidural anesthesia, as Fragmin 2500IU Injection may increase the risk of spinal or epidural hematomas. Regular monitoring of blood clotting factors may be necessary, especially during surgery or invasive procedures. Avoid alcohol abuse, which can further increase bleeding risk. The use during pregnancy and breastfeeding should be carefully assessed, and if you are planning long-distance travel, consult your healthcare provider for travel-related precautions. Follow all healthcare provider's instructions and attend follow-up appointments to ensure safe and effective treatment with Fragmin 2500IU Injection.